IXEKIZUMAB | B125521 | ELI LILLY AND CO
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Mar. 22, 2028 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 11976136(composition) · relevance 55/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
11 AI-discovered patents, sorted by relevance.
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| CASD | 2018-07-02 | Terminated 2020-03-16 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.